Thanks Chem, good of you to share. Very much looking forward to seeing the full protocol for brilacidin-OM when it's published. And hopefully already reviewed by an IRB (but not necessary - that step would be a nice catalyst shortly after though).
And of course, the "who" that will be pushing it along. I think there is still a very good chance that whomever does take on OM with us may also bring their share of the funding for it. And that is another catalyst as well.
I JUST LOVE BIO's!!!!
In reply to:
And of course, the "who" that will be pushing it along. I think there is still a very good chance that whomever does take on OM with us may also bring their share of the funding for it. And that is another catalyst as well.
I JUST LOVE BIO's!!!!
In reply to:
Quote:I attended the meeting with about 15 other shareholders. I will summarize later as I am on the road.
Highlights:
B-OM...phase 3 will need 300 patients per FDA. FDA is on board with going to phase 3...trying to partner with mid to small pharma.
Term sheet from last August would have been significant for all shareholders. Management change at BP caused it to fall through.
Authorization for 300M shares passed and they go into escrow for MFO purposes
Constantly in discussions with potential partners.
Both Leo and Art were there and appear genuine
More to come later.
Read More: https://investorshangout.com/post/newpost/873...z603irPcuZ